Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical TreatmentUniversity Hospital, MontpellierNot Yet RecruitingNot Applicable
NCT07569887Not Yet Recruiting
Not Applicable
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocogni...University Hospital, Mont...
NCT07569523
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNot Yet Recruiting
NCT07569523Not Yet Recruiting
—
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Rece...
NCT07570212
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersChangping LaboratoryRecruitingNot Applicable
NCT07570212Recruiting
Not Applicable
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersChangping Laboratory
NCT07569497
Physical Activity Maintenance Intervention for People With StrokeNorthern Ireland Chest Heart and StrokeActive Not RecruitingNot Applicable
NCT07569497Active Not Recruiting
Not Applicable
Physical Activity Maintenance Intervention for People With StrokeNorthern Ireland Chest He...
NCT07568613
Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate CancerGerman Oncology Center, CyprusRecruitingNot Applicable
NCT07568613Recruiting
Not Applicable
Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Pr...German Oncology Center, C...
NCT07569484
Effectiveness of Dry Needling in Athletes With Chronic Hamstring StrainCairo UniversityNot Yet RecruitingNot Applicable
NCT07569484Not Yet Recruiting
Not Applicable
Effectiveness of Dry Needling in Athletes With Chronic Hamstring StrainCairo University
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07570784
Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey PlayersDalarna County Council, SwedenNot Yet Recruiting
NCT07570784Not Yet Recruiting
—
Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Fe...Dalarna County Council, S...
NCT07571109
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571109Not Yet Recruiting
Phase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571213
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU AdmissionsRegion DalarnaCompleted
NCT07571213Completed
—
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National...Region Dalarna
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07570186
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsOnconic Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07570186Not Yet Recruiting
Phase 1
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy...Onconic Therapeutics Inc.
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07571031
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell CarcinomaFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07571031Not Yet Recruiting
—
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of...Fondazione Policlinico Un...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 13 (15%)
Phase 22 (10%)
Phase 31 (5%)